📊 Score Breakdown
Offering Ability
40
Cash Runway
40
Float Risk
45
Warrant Exposure
40
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for XLO.
💹 Market Data
Market Cap$55.63M
Shares Outstanding5.78M
Float3.65M
Cash$150.33M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 93.8% shares (2026Q1 vs prior)
2 institutional holders · 2.45M shares
#1
MORGAN STANLEY
1.80M shares
#2
GILEAD SCIENCES, INC.
650.4K shares
📉 Short Interest
Short Interest171.4K
Days to Cover1.8
% of Float4.7%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
4
INSIDER TRANSACTION
Mar 30, 2026
4
INSIDER TRANSACTION
Feb 17, 2026
8-K
8K EVENT
Feb 12, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔗 Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:
🔬 More Research for XLO
📊 XLO FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 XLO Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.